What Are Collagen Hybridizing Peptides?

Collagen Hybridizing Peptides (CHPs) are short peptides that selectively target damaged and remodeling collagen for applications in therapeutics, cosmetics, drug delivery systems, and life science tools.

Collagen Damage: The Hidden Driver of Disease

In many diseases, collagen damage disrupts normal cell communication, tissue structure, and repair processes—driving inflammation, accelerating tissue breakdown, and contributing to poor health outcomes. Addressing this fundamental issue opens new possibilities for therapeutic intervention across multiple conditions.  

Our Breakthrough Approach: bioACTIVE CHPs

3Helix's bioACTIVE Collagen Hybridizing Peptides (CHPs) selectively target damaged & remodeling collagen; areas traditional therapies overlook. By presenting natural, collagen-based binding sites, CHPs enable proper cell recognition and interaction.

This interaction promotes a localized, anti-inflammatory response addressing the underlying cause of tissue damage across a wide array of diseases.

The Next Generation of bioACTIVE CHPs

3Helix is advancing a new generation of bioACTIVE CHPs that both target sites of tissue damage and deliver therapeutic payloads. Combining targeted delivery with our proprietary sequences enhances therapeutic efficacy while reducing systemic side effects.